Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Antibody- and cell-based immunotherapies rely on the capacity of immune effectors to recognize and eliminate tumor cells. However, current in vitro cytotoxicity assays offer limited resolution, throughput, and mechanistic insight into which immune populations mediate killing. To address this gap, we developed a first-in-class, multiplexed mass cytometry platform that quantifies both effector-tumor binding and functional cytotoxicity at single-cell resolution across diverse immune conditions and therapeutic formats.